A Japanese research team found that the oxidized form of glutathione (GSSG) may protect heart tissue by modifying a key protein, potentially offering a novel therapeutic approach for ischemic heart failure.
A new study by researchers in Japan suggests that the mitochondria, often called the powerhouse of the cell, could be a key target for therapies aimed at mitigating or reversing heart failure.
In experiments using mice and human heart cell lines, the researchers discovered that a molecular marker typically associated with cellular damage may actually have a protective role in the heart, particularly during heart failure. Their findings, published in Nature Communications, identify a specific protein modification that helps safeguard heart tissue in low-oxygen conditions, such as those following a heart attack.
"The primary role of myocardial mitochondria is to sustain high energy production while maintaining intracellular redox balance," said first author Akiyuki Nishimura, project associate professor in the Division of Cardiocirculatory Signaling at the National Institute for Physiological Sciences (NIPS), one of the National Institutes of Natural Sciences (NINS), in Japan. "Oxidative stress due to the accumulation of reactive oxygen species (ROS) and ROS-derived electrophiles is believed to exacerbate the prognosis of ischemic, or low-oxygen, heart diseases.
Mitochondria typically power the cell and help maintain homeostasis by balancing life-sustaining — and potentially ending — oxidation-reduction (redox) reactions. These involve transferring electrons, with the oxidized molecule losing electrons and the reduced one gaining electrons. An imbalance in this exchange can increase oxidative stress, which can lead to cellular damage.
Investigating the Role of GSSG in Heart Protection
"Oxidative stress caused by increased reactive oxygen species production is a key feature of ischemic heart disease and is believed to be involved in the development and progression of heart failure," Nishimura said. "Therefore, several clinical studies targeting oxidative stress have been performed to improve the outcome of heart failure patients but most of them have failed."
Rates of oxidative stress are indicated by levels of GSSG, the oxidized form of glutathione (GSH), an antioxidant that helps the body repair damage. In health, there should be much more GSH than GSSG. The lower the ratio between the two molecules, the more GSSG, the more likely there is lasting oxidative damage in the body.
However, Nishimura said, specific studies to investigate if the obvious answer of increasing GSH would improve outcomes have failed.
In this study, the researchers analyzed whether GSSG might be the solution. They found that after heart damage caused by low-oxygen, GSSG modified a sulfur-containing amino acid on a protein called Drp1, protecting mitochondrial function. This protects the heart, the researchers said, because mitochondria can become dysregulated and cause further damage, including heart failure, without enough oxygen.
"These findings prove the breakthrough therapeutic potential of GSSG for ischemic chronic heart failure," Nishimura said, noting that the team next plans to investigate whether sulfur-based redox reactions have principal roles in disease progression in other organ systems beyond the cardiovascular system.
Reference: "Polysulfur-based bulking of dynamin-related protein 1 prevents ischemic sulfide catabolism and heart failure in mice" by Akiyuki Nishimura, Seiryo Ogata, Xiaokang Tang, Kowit Hengphasatporn, Keitaro Umezawa, Makoto Sanbo, Masumi Hirabayashi, Yuri Kato, Yuko Ibuki, Yoshito Kumagai, Kenta Kobayashi, Yasunari Kanda, Yasuteru Urano, Yasuteru Shigeta, Takaaki Akaike and Motohiro Nishida, 2 January 2025, Nature Communications.
DOI: 10.1038/s41467-024-55661-5
Funding: Japan Science and Technology Agency, the Japan Society for the Promotion of Science; the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Joint Research of the Exploratory Research Center on Life and Living Systems, Japan Agency for Medical Research and Development, Sumitomo Foundation, Naito Foundation, Smoking Research Foundation
News
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
